Shiqi Li
Nanchang University(CN)Changsha Medical University(CN)Hunan University(CN)Shanghai Jiao Tong University(CN)Dalian Medical University(CN)Nanjing University of Information Science and Technology(CN)Sichuan University(CN)Mudanjiang Medical University(CN)Second Affiliated Hospital of Chongqing Medical University(CN)Shanghai University of Traditional Chinese Medicine(CN)117th Hospital of People's Liberation Army(CN)People's Liberation Army 401 Hospital(CN)Second Affiliated Hospital of Nanchang University(CN)Traditional Chinese Medicine Hospital of Kunshan(CN)Zhongshan Hospital(CN)Second Affiliated Hospital of Nanjing Medical University(CN)Micro & Nano Research Institute(CN)Guangdong Provincial Center for Disease Control and Prevention(CN)Chengdu Institute of Biology(CN)University of Chinese Academy of Sciences(CN)Southern Medical University(CN)Ocean University of China(CN)Xinxiang Medical University(CN)Nanjing Medical University(CN)Chongqing Medical University(CN)Northwest A&F University(CN)
Publications by Year
Research Areas
Pituitary Gland Disorders and Treatments, CAR-T cell therapy research, Growth Hormone and Insulin-like Growth Factors, Meningioma and schwannoma management, Glioma Diagnosis and Treatment
Most-Cited Works
- → Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers(2017)436 cited
- → Recurrent gain-of-function USP8 mutations in Cushing's disease(2015)351 cited
- → The genome-wide mutational landscape of pituitary adenomas(2016)169 cited
- → Preparation of aminated fish scale collagen and oxidized sodium alginate hybrid hydrogel for enhanced full-thickness wound healing(2020)144 cited
- → Identification of recurrent USP48 and BRAF mutations in Cushing’s disease(2018)143 cited
- → Ischemic Duration and Frequency Determines AKI-to-CKD Progression Monitored by Dynamic Changes of Tubular Biomarkers in IRI Mice(2019)136 cited